Moreover, Critical unwell patients with COVID-19 and diabetes have high insulin requirements and poorer time in optimal target range for blood glucose during peak inflammatory response (37), which indicating the insulin treatment is necessary during the late stage of COVID-19 disease. The gene discussed is INS; the disease is COVID-19.